Table of Contents
1. Research Framework
1.1. Research Objective
1.2. Product Overview
1.3. Market Segmentation
2. Executive Summary
3. Global Anti-Aging Market Insights
3.1. Industry Value Chain Analysis
3.1.1. DROC Analysis
3.1.2. Growth Drivers
3.1.2.1. Increase in Disposable Income
3.1.2.2. Increasing Awareness of Aging Signs in Young Generations
3.1.2.3. Growing Demand for Anti-Aging Products
3.1.3. Restraints
3.1.3.1. High Cost of Raw Materials
3.1.4. Opportunities
3.1.4.1. Advancements in Technology
3.1.5. Challenges
3.2. Technology Advancements/Recent Developments
3.3. Regulatory Framework
3.4. Porter's Five Forces Analysis
3.4.1. Bargaining Power of Suppliers
3.4.2. Bargaining Power of Buyers
3.4.3. Threat of New Entrants
3.4.4. Threat of Substitutes
3.4.5. Intensity of Rivalry
4. Global Anti-Aging Market Overview
4.1. Market Size & Forecast, 2019-2029
4.1.1. By Value (USD Million)
4.2. Market Share & Forecast
4.2.1. By Product
4.2.1.1. Anti-Wrinkle
4.2.1.2. Hair Color
4.2.1.3. UV Absorbers
4.2.1.4. Anti-Stretch Marks
4.2.2. By Device
4.2.2.1. Radiofrequency
4.2.2.2. Laser
4.2.2.3. Anti-Cellulite
4.2.2.4. Microdermabrasion
4.2.2.5. Others
4.2.3. By Treatment
4.2.3.1. Hair Restoration
4.2.3.2. Anti-Pigmentation
4.2.3.3. Anti-Adult Acne
4.2.3.4. Liposuction
4.2.3.5. Breast Augmentation
4.2.3.6. Chemical Peel
4.2.4. By Demography
4.2.4.1. Generation X
4.2.4.2. Baby Boomer
4.2.4.3. Generation Y
4.2.5. By Region
4.2.5.1. North America
4.2.5.2. Europe
4.2.5.3. Asia Pacific (APAC)
4.2.5.4. Latin America (LATAM)
4.2.5.5. Middle East and Africa (MEA)
5. North America Anti-Aging Market
5.1. Market Size & Forecast, 2019-2029
5.1.1. By Value (USD Million)
5.2. Market Share & Forecast
5.2.1. By Product
5.2.2. By Device
5.2.3. By Treatment
5.2.4. By Demography
5.2.5. By Country
5.2.5.1. US
5.2.5.1.1. By Product
5.2.5.1.2. By Device
5.2.5.1.3. By Treatment
5.2.5.1.4. By Demography
5.2.5.2. Canada
5.2.5.2.1. By Product
5.2.5.2.2. By Device
5.2.5.2.3. By Treatment
5.2.5.2.4. By Demography
6. Europe Anti-Aging Market
6.1. Market Size & Forecast, 2019-2029
6.1.1. By Value (USD Million)
6.2. Market Share & Forecast
6.2.1. By Product
6.2.2. By Device
6.2.3. By Treatment
6.2.4. By Demography
6.2.5. By Country
6.2.5.1. Germany
6.2.5.1.1. By Product
6.2.5.1.2. By Device
6.2.5.1.3. By Treatment
6.2.5.1.4. By Demography
6.2.5.2. UK
6.2.5.2.1. By Product
6.2.5.2.2. By Device
6.2.5.2.3. By Treatment
6.2.5.2.4. By Demography
6.2.5.3. Italy
6.2.5.3.1. By Product
6.2.5.3.2. By Device
6.2.5.3.3. By Treatment
6.2.5.3.4. By Demography
6.2.5.4. France
6.2.5.4.1. By Product
6.2.5.4.2. By Device
6.2.5.4.3. By Treatment
6.2.5.4.4. By Demography
6.2.5.5. Spain
6.2.5.5.1. By Product
6.2.5.5.2. By Device
6.2.5.5.3. By Treatment
6.2.5.5.4. By Demography
6.2.5.6. The Netherlands
6.2.5.6.1. By Product
6.2.5.6.2. By Device
6.2.5.6.3. By Treatment
6.2.5.6.4. By Demography
6.2.5.7. Rest of Europe
6.2.5.7.1. By Product
6.2.5.7.2. By Device
6.2.5.7.3. By Treatment
6.2.5.7.4. By Demography
7. Asia-Pacific Anti-Aging Market
7.1. Market Size & Forecast, 2019-2029
7.1.1. By Value (USD Million)
7.2. Market Share & Forecast
7.2.1. By Product
7.2.2. By Device
7.2.3. By Treatment
7.2.4. By Demography
7.2.5. By Country
7.2.5.1. China
7.2.5.1.1. By Product
7.2.5.1.2. By Device
7.2.5.1.3. By Treatment
7.2.5.1.4. By Demography
7.2.5.2. India
7.2.5.2.1. By Product
7.2.5.2.2. By Device
7.2.5.2.3. By Treatment
7.2.5.2.4. By Demography
7.2.5.3. Japan
7.2.5.3.1. By Product
7.2.5.3.2. By Device
7.2.5.3.3. By Treatment
7.2.5.3.4. By Demography
7.2.5.4. South Korea
7.2.5.4.1. By Product
7.2.5.4.2. By Device
7.2.5.4.3. By Treatment
7.2.5.4.4. By Demography
7.2.5.5. Australia & New Zealand
7.2.5.5.1. By Product
7.2.5.5.2. By Device
7.2.5.5.3. By Treatment
7.2.5.5.4. By Demography
7.2.5.6. Indonesia
7.2.5.6.1. By Product
7.2.5.6.2. By Device
7.2.5.6.3. By Treatment
7.2.5.6.4. By Demography
7.2.5.7. Malaysia
7.2.5.7.1. By Product
7.2.5.7.2. By Device
7.2.5.7.3. By Treatment
7.2.5.7.4. By Demography
7.2.5.8. Singapore
7.2.5.8.1. By Product
7.2.5.8.2. By Device
7.2.5.8.3. By Treatment
7.2.5.8.4. By Demography
7.2.5.9. Philippines
7.2.5.9.1. By Product
7.2.5.9.2. By Device
7.2.5.9.3. By Treatment
7.2.5.9.4. By Demography
7.2.5.10. Vietnam
7.2.5.10.1. By Product
7.2.5.10.2. By Device
7.2.5.10.3. By Treatment
7.2.5.10.4. By Demography
7.2.5.11. Rest of APAC
7.2.5.11.1. By Product
7.2.5.11.2. By Device
7.2.5.11.3. By Treatment
7.2.5.11.4. By Demography
8. Latin America Anti-Aging Market
8.1. Market Size & Forecast, 2019-2029
8.1.1. By Value (USD Million)
8.2. Market Share & Forecast
8.2.1. By Product
8.2.2. By Device
8.2.3. By Treatment
8.2.4. By Demography
8.2.5. By Country
8.2.5.1. Brazil
8.2.5.1.1. By Product
8.2.5.1.2. By Device
8.2.5.1.3. By Treatment
8.2.5.1.4. By Demography
8.2.5.2. Mexico
8.2.5.2.1. By Product
8.2.5.2.2. By Device
8.2.5.2.3. By Treatment
8.2.5.2.4. By Demography
8.2.5.3. Argentina
8.2.5.3.1. By Product
8.2.5.3.2. By Device
8.2.5.3.3. By Treatment
8.2.5.3.4. By Demography
8.2.5.4. Peru
8.2.5.4.1. By Product
8.2.5.4.2. By Device
8.2.5.4.3. By Treatment
8.2.5.4.4. By Demography
8.2.5.5. Rest of LATAM
8.2.5.5.1. By Product
8.2.5.5.2. By Device
8.2.5.5.3. By Treatment
8.2.5.5.4. By Demography
9. Middle East & Africa Anti-Aging Market
9.1. Market Size & Forecast, 2019-2029
9.1.1. By Value (USD Million)
9.2. Market Share & Forecast
9.2.1. By Product
9.2.2. By Device
9.2.3. By Treatment
9.2.4. By Demography
9.2.5. By Country
9.2.5.1. Saudi Arabia
9.2.5.1.1. By Product
9.2.5.1.2. By Device
9.2.5.1.3. By Treatment
9.2.5.1.4. By Demography
9.2.5.2. UAE
9.2.5.2.1. By Product
9.2.5.2.2. By Device
9.2.5.2.3. By Treatment
9.2.5.2.4. By Demography
9.2.5.3. Qatar
9.2.5.3.1. By Product
9.2.5.3.2. By Device
9.2.5.3.3. By Treatment
9.2.5.3.4. By Demography
9.2.5.4. Kuwait
9.2.5.4.1. By Product
9.2.5.4.2. By Device
9.2.5.4.3. By Treatment
9.2.5.4.4. By Demography
9.2.5.5. South Africa
9.2.5.5.1. By Product
9.2.5.5.2. By Device
9.2.5.5.3. By Treatment
9.2.5.5.4. By Demography
9.2.5.6. Nigeria
9.2.5.6.1. By Product
9.2.5.6.2. By Device
9.2.5.6.3. By Treatment
9.2.5.6.4. By Demography
9.2.5.7. Algeria
9.2.5.7.1. By Product
9.2.5.7.2. By Device
9.2.5.7.3. By Treatment
9.2.5.7.4. By Demography
9.2.5.8. Rest of MEA
9.2.5.8.1. By Product
9.2.5.8.2. By Device
9.2.5.8.3. By Treatment
9.2.5.8.4. By Demography
10. Competitive Landscape
10.1. List of Key Players and Their Offerings
10.2. Global Anti-Aging Company Market Share Analysis, 2022
10.3. Competitive Benchmarking, By Operating Parameters
10.4. Key Strategic Developments (Mergers, Acquisitions, Partnerships, etc.)
11. Impact of Covid-19 on Global Anti-Aging Market
12. Company Profile (Company Overview, Financial Matrix, Competitive Landscape, Key Personnel, Key Competitors, Contact Address, Strategic Outlook, SWOT Analysis)
12.1. Unilever Group
12.2. GALDERMA LABORATORIES L.P.
12.3. Procter & Gamble (P&G) Company
12.4. Nu Skin Enterprises Inc.
12.5. Hologic Inc.
12.6. Pierre Fabre S.A.
12.7. Shiseido Company Limited
12.8. Candela Corporation
12.9. Home Skinovations Ltd.
12.10. Estee Lauder
12.11. Johnson & Johnson
12.12. ZO Skin Health, Inc.
12.13. L'Oreal Paris
12.14. Beiersdorf
12.15. PHYTOMER
12.16. Other Prominent Players
13. Key Strategic Recommendations
14. Research Methodology
14.1. Qualitative Research
14.1.1. Primary & Secondary Research
14.2. Quantitative Research
14.3. Market Breakdown & Data Triangulation
14.3.1. Secondary Research
14.3.2. Primary Research
14.4. Breakdown of Primary Research Respondents, By Region
14.5. Assumptions & Limitations